volinanserin (M100907)

DRUG2 trials

Sponsors

Sanofi

Conditions

Sleep Initiation and Maintenance Disorders

Phase 3

Efficacy and Safety of M100907 on Sleep Maintenance Insomnia With a Sub-study in Stable Type II Diabetes Mellitus

CompletedNCT00495885

SanofiSleep Initiation and Maintenance Disorders

Start: 2007-06-30End: 2008-10-31Updated: 2016-05-26

Comparison of Volinanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties

TerminatedNCT00788515

SanofiSleep Initiation and Maintenance Disorders

Start: 2008-11-30End: 2009-01-31Updated: 2009-08-28